Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05165433
Title Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY)
Acronym FORTIFY
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PsiOxus Therapeutics Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR

Facility Status City State Zip Country Details
Providence Medical Foundation NOT_YET_RECRUITING Santa Monica California 90404 United States Details
UCLA RECRUITING Santa Monica California 90404 United States Details
Moffitt-Advent Health Clinical Research Unit NOT_YET_RECRUITING Celebration Florida 34747 United States Details
Perelman Center of Advanced Medicine RECRUITING Philadelphia Pennsylvania 19104 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
The Clatterbridge Cancer Centre NHS Foundation Trust NOT_YET_RECRUITING Liverpool Lancashire L7 8YA United Kingdom Details
Churchill Hospital, Oxford University Hospitals NHS Foundation Trust RECRUITING Oxford Oxfordshire OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field